1-3 of 3
Yifei Zhang
Close
Sort by
Journal Articles

Belantamab Mafadotin in Patients with Relapsed/Refractory AL Amyloidosis with Myeloma

Yifei Zhang, Amandeep Godara, Stacey Pan, Denis Toskic, Teresa Fogaren, Douglas W. Sborov, Raymond Comenzo, Ankit Kansagra
Journal: Blood
Blood (2021) 138 (Supplement 1): 1670.
https://doi.org/10.1182/blood-2021-151365
Published: 2021
Journal Articles

Therapeutic Activity of Combining BCL-2 and HMG-CoA Reductase Inhibition in Systemic Light-Chain Amyloidosis

Ping Zhou, MDPhD, Hashim Mann, MD, Xun Ma, DMD, MSc, PhD, Teresa Fogaren, NP, Yifei Zhang, MD, Denis Toskic, BS, Chakra P Chaulagain, MD, Cindy Varga, MDBSc, Raymond L. Comenzo, MD, Amandeep Godara, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-142656
Published: 2020
Journal Articles

Barriers and Opportunities in Accrual of HIV-Positive Minority Underserved Patients with Non-Hodgkin Lymphoma, into AIDS Malignancy Consortium (AMC) Clinical Trials: A Retrospective 12- Year Single Institution Experience

Sakshi Jasra, MD, Ali Mustafa, Amara Gayathri Nandikolla, MD, Urvi A Shah, MD, Yifei Zhang, MD, Ioannis Mantzaris, MD, Aditi Shastri, MD, Adam F. Binder, MD, Ira Braunschweig, MD, Noah Kornblum, MD, Amit Verma, MD, David M. Aboulafia, MD, Murali Janakiram, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4135.
https://doi.org/10.1182/blood.V130.Suppl_1.4135.4135
Published: 2017